Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Highly diluted atropine eye drops to slow myopia progression in children
2020-002046-16Phase 3Active
- Sponsor
- Fakultní nemocnice Brno
- Start
- May 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atropine in myopia (3 arms), sponsored by Fakultní nemocnice Brno. Primary endpoint: Change in axial eye length at 12 months (0.02% atropine vs placebo). Started May 2020; status: active.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2020-002046-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002046-16.